RxDoctor Payments Data

Amanda Harrell, DO

Internal Medicine · Joplin, MONPI 1891138848

Payments from drug & device makers

$3,358in general payments, 2019–2025

Across 214 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$382
  • AbbVie$349
  • Amgen$337
  • AstraZeneca$286
  • Lilly USA, LLC$244
  • GSK$166
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$3,358100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,358 in reported general payments places this provider in the 85th percentile of 2,097 internal medicine providers in Missouri.

See all internal medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$99,205
Medicare patients
397
Services billed
1,193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide134$157,431
JardianceEmpagliflozin124$125,280
TrulicityDulaglutide100$115,855
MounjaroTirzepatide88$108,930
LinzessLinaclotide147$103,511
EliquisApixaban135$97,410
FarxigaDapagliflozin Propanediol58$50,790
ProliaDenosumab29$49,758
RybelsusSemaglutide15$42,578
Repatha SureclickEvolocumab65$36,073
Synjardy XrEmpagliflozin/Metformin Hcl26$29,372
XareltoRivaroxaban38$28,341
Breztri AerosphereBudesonide/Glycopyr/Formoterol41$28,274
JanuviaSitagliptin Phosphate40$26,188
Tresiba Flextouch U-200Insulin Degludec14$24,878

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$244$224,785188 claims
Novo NordiskOzempic, Rybelsus$382$200,009149 claims
Boehringer IngelheimJardiance, Synjardy Xr, Spiriva Respimat$95$166,833162 claims
AbbVieLinzess$349$103,511147 claims
PfizerEliquis$161$97,410135 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$286$95,309145 claims
AmgenProlia$337$49,75829 claims
GSKTrelegy Ellipta, Breo Ellipta, Arexvy$166$46,14597 claims
Johnson & JohnsonXarelto$21$28,34138 claims
MerckJanuvia$52$26,18840 claims
Astellas Pharma US IncMyrbetriq$41$20,14031 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$89$7,25713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,097 internal medicine providers in Missouri.

Other internal medicine in Joplin

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →